Examkin

Question

Difficulty: HardPediatric Infectious Diseases

Evaluate the following pediatric patients presenting with signs and symptoms concerning for acute bacterial meningitis. Which initial empiric intravenous antimicrobial regimen is most appropriate for each patient's clinical presentation? Match each patient to the correct regimen.

  • A 12-day-old infant born at 39 weeks gestation presenting with temperature instability, poor feeding, lethargy, and a full anterior fontanelle.Ampicillin, cefotaxime, and gentamicin
  • A 7-week-old infant brought to the emergency department with a temperature of 39.2°C (102.6°F), marked irritability, and a focal motor seizure.Ampicillin, ceftriaxone, and vancomycin
  • A 5-year-old child presenting with acute onset of fever, severe headache, photophobia, nuchal rigidity, and a rapidly spreading petechial rash.Ceftriaxone and vancomycin
  • A 12-year-old adolescent who underwent a craniotomy for tumor resection two weeks ago, now presenting with high fever, vomiting, and altered mental status.Vancomycin and cefepime

Answer

The correct matches align each pediatric age group or specific risk factor (e.g., neurosurgery) with the antimicrobial regimen that covers the most likely causative pathogens for that demographic.
Each match correctly pairs the patient's demographic and clinical risk profile with the specific empiric antibiotic regimen that safely covers their most likely meningeal pathogens.

Step-by-Step Solution

1
Analyze the age and risk factors of the 12-day-old neonate.
The patient is in the neonatal period (< 28 days), where primary pathogens are Group B Streptococcus, E. coli, and Listeria monocytogenes.
This determines the need for ampicillin (for Listeria) and cefotaxime with gentamicin (for GBS and Gram-negatives), while explicitly avoiding ceftriaxone to prevent kernicterus.
2
Evaluate the 7-week-old infant's presentation.
The patient falls into the 1 to 3 months transitional age group, which is susceptible to both neonatal and childhood pathogens.
This necessitates broad coverage combining ampicillin (for Listeria) with ceftriaxone and vancomycin (for S. pneumoniae and N. meningitidis).
3
Assess the 5-year-old child's symptoms.
The patient has a classic presentation of childhood meningitis, predominantly caused by S. pneumoniae and N. meningitidis.
Vancomycin and ceftriaxone provide optimal empiric coverage without the need for Listeria or Pseudomonas coverage.
4
Review the 12-year-old adolescent's recent neurosurgical history.
Recent craniotomy places the patient at high risk for nosocomial pathogens, particularly MRSA and Pseudomonas aeruginosa.
Vancomycin (for MRSA) and cefepime (an antipseudomonal cephalosporin) are required for adequate healthcare-associated meningitis coverage.

Key Concept

Empiric antimicrobial therapy for pediatric meningitis is strictly determined by age-specific pathogen susceptibility and specific risk factors (e.g., neurosurgery), ensuring coverage for Listeria in young infants and Pseudomonas/MRSA in postsurgical patients.
Rate this question

Topics

Pediatric Infectious Diseases

More questions from this topic